Article content
They laid out what’s at stake: a return to school that’s as safe and normal as possible, protection against a now-dominant, more transmissible variant that “will seek out unvaccinated individuals,” and the severity of an expected COVID-19 flare-up in the fall, as colder weather returns and people move indoors.
We apologize, but this video has failed to load.
Try refreshing your browser. COVID-19: Ontario reports 146 additional cases Back to video
“Delta will want to surge and return in September, if not earlier. All you have to do is look around the globe and see the increased activity in countries where Delta has gone unchecked. It’s very important that we continue to prepare and respond now,” Ontario Chief Medical Officer of Health Dr. Kieran Moore said.
COVID-19: Ontario reports 146 additional cases, one in Ottawa healthing.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healthing.ca Daily Mail and Mail on Sunday newspapers.
The NACI problem and how to fix it
The volunteer panel is dispensing crucial vaccine advice meant to keep Canadians safe and healthy. But NACI desperately needs to do better on the national stage.
May 17, 2021 People wearing face masks line up to enter a COVID-19 vaccination clinic in Toronto on May 5, 2021. (Zou Zheng/Xinhua via ZUMA Press)
Monika Naus once spent an entire summer vacation reading through a final draft of the Canadian Immunization Guide. Back then, Naus was chair of the National Advisory Committee on Immunization (NACI), a panel of doctors and scientists that offers recommendations on vaccine usage to a constellation of health-care providers across Canada. Naus’s workload could be daunting, in part because the committee had little administrative support. Still, she volunteered her time for more than a decade and chaired NACI from 2003 to 2007.
TORONTO There s a new bump in the road to mass vaccination against COVID-19 in Canada. Ontario, Alberta and Saskatchewan announced on Tuesday that they will no longer administer first doses of the AstraZeneca vaccine. Reasons cited for this abrupt shift include claims of uncertain supply and worries about the rare risk of blood clots from the vaccine. However, authorities in other provinces have said that they do not plan to pause AstraZeneca inoculations, and federal health officials say they still consider the vaccine safe to use in most populations. To help Canadians understand what the science says about the AstraZeneca vaccine, CTV s Chief News Anchor and Senior Editor Lisa LaFlamme spoke with Dr. Menaka Pai of McMaster University in Hamilton, Ont. Pai is an associate professor of hematology and thromboembolism â a blood clot expert, in other words â and a member of Ontario s COVID-19 Science Advisory Table.